<DOC>
	<DOCNO>NCT00381147</DOCNO>
	<brief_summary>We look effectiveness low-dose long-term prescription clarithromycin mustard-induced chronic pulmonary lesion , especially bronchiolitis obliterans</brief_summary>
	<brief_title>Use Clarithromycin Mustard-Induced Bronchiolitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>His/her participate Documented chemical exposure Clinical , spirometric radiological finding compatible BO High Resolution Computed Tomography ( HRCT ) drug reaction trial history sensitivity macrolides diarrhea , gray stool , jaundice , eosinophilia , acute cholestatic hepatitis , pruritis , dark urine , abdominal pain , osteomatosis , depression , taste change , behavioural change , early fatigue , odynophagia , glossitis , dizziness coadminstration : terfenadine , theophylline , carbamazepine , ergotamine , dihydroergotamine , warfarin , cisapride , digoxin , triazolam , phenytoin , steroid , immunosuppressive , systemic antibiotic use drug he/she discontinue use drug potential interaction subject exit trial history lobe resection lung history exacerbation last month prior begin trial continuous need oxygen use corticosteroid last week prior trial begin Radiographic evidence pneumonia , active tuberculosis , lung carcinoma , infection necessitate use antibiotic exacerbate subject creatinine srum level normal increase ALT , AST level total bilirubin twice normal subject use drug properly</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>